AI assistant
Sending…
Xvivo Perfusion — Major Shareholding Notification 2017
Apr 18, 2017
3130_iss_2017-04-18_360ae072-150e-4262-b453-e372aeb85f46.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Xvivo Perfusion Aktiebolag
Holder
Bure Equity AB (publ)
Instrument
| Instrument | AK |
|---|---|
| Before the transaction | |
| Shares | 4,891,483 |
| Voting rights | 4,891,483 |
| Transaction | |
| Reason for major shareholding notification New share issue | |
| Date | 13/04/2017 |
| Limit for number of shares | 20 % |
| Limit for number of votes | 20 % |
| After the transaction | |
| Quantity | |
| Shares | 4,891,483 |
| Directly held voting rights | 4,891,483 |
| Indirectly held voting rights | 0 |
| Percentage | |
| Directly held shares | 18.8 % |
| Directly held voting rights | 18.8 % |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 18.8 % | 4,891,483 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled - Cash settled |
||
| Total | 18.8 % | 4,891,483 |
| Group total holdings | ||
| Voting rights 4,891,483 Percentage of voting rights 18.8 |
||
| Published 18/04/2017 17:07 |
||
| Contact | ||
| Name Max Jonson |
||
| Phone 0725087512 Email [email protected] |
||
| CLOSE |
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Xvivo Perfusion
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 27
AGM Information
2026
Apr 27
Regulatory Filings
2026
Apr 22
Regulatory Filings
2026
Apr 22
Annual Report
2026
Apr 1
Annual Report
2026
Apr 1
Proxy Solicitation & Information Statement
2026
Mar 19
Proxy Solicitation & Information Statement
2026
Mar 19
Board/Management Information
2026
Feb 20
Regulatory Filings
2026
Feb 20